CN101658643B - Medicament for treating allergic purpura - Google Patents
Medicament for treating allergic purpura Download PDFInfo
- Publication number
- CN101658643B CN101658643B CN200910018417XA CN200910018417A CN101658643B CN 101658643 B CN101658643 B CN 101658643B CN 200910018417X A CN200910018417X A CN 200910018417XA CN 200910018417 A CN200910018417 A CN 200910018417A CN 101658643 B CN101658643 B CN 101658643B
- Authority
- CN
- China
- Prior art keywords
- portions
- radix
- grams
- rhizoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating allergic purpura, which is prepared from the following raw materials in portion by weight: 25-35 portions of astragalus root, 10-14 portions of radix scrophulariae, 18-22 portions of rehmanniae praeparatum, 18-22 portions of forsythia, 18-22 portions of rehmanniae vaporata, 9-11 portions of angelica, 18-22 portions of red paeonia, 7-9 portions of cortex moutan, 18-22 portions of lithospermum, 14-16 portions of double blossom, 18-22 portions of agrimony, 5-7 portions of liquorice, 2-4 portions of safflower, 14-16 portions of salvia miltiorrhiza, 9-11 portions of sanguisorba, 9-11 portions of cattail pollen, 2-4 portions of rush, 9-11 portions of divaricate saposhnikovia root, 14-16 portions of rhizoma belamcandae, 14-16 portions of couchgrass root, 9-11 portions of medlar, 9-11 portions of indigowoad root and 9-11 portions of atractylodes macrocephala. The invention has the advantages of good curative effect, quick response, no toxic and side effects, low cost, convenient taking, treatment of both principal and secondary aspect of disease and no relapse, and can ensure that patients obtain good clinical effect after taking for 3-5 courses.
Description
(1) technical field
The present invention relates to Chinese medicine composition, particularly a kind of medicine for the treatment of anaphylactoid purpura.
(2) background technology
Anaphylactoid purpura is a kind of allergic disease, mainly involves capillary wall and bleeding takes place.Show as ecchymosis clinically, the symptom of arthralgia in various degree and gastrointestinal tract, kidney aspect, lab testing can no abnormally be found.Modern medicine thinks that primary disease may act on human body by various sensitizing agent, brings out by allergy.Though it is more to treat the medicine of this disease at present, mostly is Western medicine greatly, though these Western medicine have certain curative effect, it exists the phenomenon of toxic and side effects also relatively more serious, and the patient is easy to generate the medicine dependence; And western medicine is longer the course of treatment, and lacks the method that recurs of preventing; It is higher that existing in addition Western medicine ubiquity medical expense, and the also less-than-ideal problem of curative effect, and therefore, the result of use of existing treatment allergy purpura still is not ideal.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, the medicine of the treatment anaphylactoid purpura that provide a kind of good effect, instant effect, have no side effect, cost is low.
The present invention is achieved through the following technical solutions:
The medicine of treatment anaphylactoid purpura of the present invention, its special character is: the raw material by following parts by weight is made: Radix Astragali 25-35 part, Radix Scrophulariae 10-14 part, Radix Rehmanniae 18-22 part, Fructus Forsythiae 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Angelicae Sinensis 9-11 part, Radix Paeoniae Rubra 18-22 part, Cortex Moutan 7-9 part, Radix Arnebiae (Radix Lithospermi) 18-22 part, Flos Lonicerae 14-16 part, Herba Agrimoniae 18-22 part, Radix Glycyrrhizae 5-7 part, Flos Carthami 2-4 part, Radix Salviae Miltiorrhizae 14-16 part, Radix Sanguisorbae 9-11 part, Pollen Typhae 9-11 part, Medulla Junci 2-4 part, Radix Saposhnikoviae 9-11 part, Rhizoma Belamcandae 14-16 part, Rhizoma Imperatae 14-16 part, Fructus Lycii 9-11 part, Radix Isatidis 9-11 part, Rhizoma Atractylodis Macrocephalae 9-11 part, Fructus Gardeniae 9-11 part, Radix Scutellariae (parched) 18-22 part, Rhizoma Osmundae 9-11 part, Herba Cirsii 21-27 part.
Preparation method: decocting method, decocting twice merges filtrate twice, is divided into two parts.
Usage and dosage: oral, sooner or later each once, every day one pair, 30 days one courses of treatment.
Clinical observation: the present invention carries out clinical observation treatment to 200 routine patients, and the age 5, symptom was petechia, purpura and ecchymosis to 40 years old.Take medicine of the present invention, oral, sooner or later respectively once, every day one, pair, was total to 3-5 the course of treatment at 30 days one courses of treatment.
(1) efficacy assessment standard:
Cure: the clinical symptoms sign disappears, and it is normal that functional activity recovers, and subcutaneous hemorrhage disappears, and every inspection index is normal.
Produce effects: the basic or big portion of clinical symptoms sign disappears, and subcutaneous hemorrhage disappears substantially, and every inspection index is most of normal.
Effectively: clinical symptoms is clearly better or takes a turn for the better, and subcutaneous hemorrhage partly disappears, and every inspection indexing section is normal.
Invalid: the clinical symptoms sign does not have improvement, and subcutaneous hemorrhage is not seen disappearance, and every inspection index is still undesired.
(2) therapeutic effect:
Clinical cure 186 examples account for 93%; Produce effects 6 examples account for 3%; Effective 8 examples account for 4%; Invalid 0 example; Total effective rate 100%.All have no adverse reaction during the treatment, point out medicine of the present invention to have no side effect drug safety.
Model case:
1. clock lacks scholar, man, 10 years old, Jinan City's Licheng District, be anaphylactoid purpura through Qianfo Mount, Jinan City hospital diagnosis in January, 1997, concurrent gastrointestinal type symptom, hospitalization 10 days, the commentaries on classics of not getting better, introduce the here diagnosis and treatment through the friend, fully recover after 3 courses of treatment of taking medicine, follow up a case by regular visits to so far not recurrence.
2. Lee is little clean, the woman, and 23 years old, the Shizhong District, Jinan City, be anaphylactoid purpura through the Shandong hospital diagnosis in February, 1997, concurrent joint type symptom, the hospitalization two weeks does not have improvement, comes the here diagnosis and treatment, the recovery from illness in 5 months of taking medicine, not recurrence so far.
3. become the autumn bright, man, 7 years old, Jinan City's Tianqiao District, the big Second Academy in 15 Nikkei mountains March in 1997 is diagnosed as anaphylactoid purpura, concurrent joint type symptom, hospitalization 10 days, the commentaries on classics of not getting better, introduce the here diagnosis and treatment through others, fully recover after 3 courses of treatment of taking medicine, drug withdrawal is not recurrence so far.
The invention has the beneficial effects as follows, good effect, instant effect has no side effect, cost is low, taking convenience, treating both the principal and secondary aspects of a disease does not recur, take 3-5 the course of treatment patient just can receive good clinical effectiveness.
(4) specific embodiment
Embodiment 1
The medicine of the treatment anaphylactoid purpura that this law is bright is made by the raw material of following weight: the Radix Astragali 30 grams, Radix Scrophulariae 12 grams, the Radix Rehmanniae 20 grams, Fructus Forsythiae 20 grams, Radix Rehmanniae Preparata 20 grams, Radix Angelicae Sinensis 10 grams, Radix Paeoniae Rubra 20 grams, Cortex Moutan 8 grams, Radix Arnebiae (Radix Lithospermi) 20 grams, Flos Lonicerae 15 grams, Herba Agrimoniae 20 grams, Radix Glycyrrhizae 6 grams, Flos Carthami 3 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Sanguisorbae 10, Pollen Typhae 10 grams, Medulla Junci 3 grams, Radix Saposhnikoviae 10 grams, Rhizoma Belamcandae 15 grams, Rhizoma Imperatae 15 grams, Fructus Lycii 10 grams, Radix Isatidis 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Fructus Gardeniae 10 grams, Radix Scutellariae (parched) 20 grams, Rhizoma Osmundae 10 grams, Herba Cirsii 24 grams.
Preparation method: decocting method, decocting twice merges filtrate twice, is divided into two parts.
Usage and dosage: oral, sooner or later each once, every day one pair, 30 days one courses of treatment.
Embodiment 2
The medicine of treatment anaphylactoid purpura of the present invention is made by the raw material of following weight: the Radix Astragali 25 grams, Radix Scrophulariae 10 grams, the Radix Rehmanniae 18 grams, Fructus Forsythiae 18 grams, Radix Rehmanniae Preparata 18 grams, Radix Angelicae Sinensis 9 grams, Radix Paeoniae Rubra 18 grams, Cortex Moutan 7 grams, Radix Arnebiae (Radix Lithospermi) 18 grams, Flos Lonicerae 14 grams, Herba Agrimoniae 18 grams, Radix Glycyrrhizae 5 grams, Flos Carthami 2 grams, Radix Salviae Miltiorrhizae 14 grams, Radix Sanguisorbae 9 grams, Pollen Typhae 9 grams, Medulla Junci 2 grams, Radix Saposhnikoviae 9 grams, Rhizoma Belamcandae 14 grams, Rhizoma Imperatae 14 grams, Fructus Lycii 9 grams, Radix Isatidis 9 grams, the Rhizoma Atractylodis Macrocephalae 9 grams, Fructus Gardeniae 9 grams, Radix Scutellariae (parched) 18 grams, Rhizoma Osmundae 9 grams, Herba Cirsii 21 grams.
All the other are identical with embodiment 1.
Embodiment 3
The medicine of treatment anaphylactoid purpura of the present invention is made by the raw material of following weight: the Radix Astragali 35 grams, Radix Scrophulariae 14 grams, the Radix Rehmanniae 22 grams, Fructus Forsythiae 22 grams, Radix Rehmanniae Preparata 22 grams, Radix Angelicae Sinensis 11 grams, Radix Paeoniae Rubra 22 grams, Cortex Moutan 9 grams, Radix Arnebiae (Radix Lithospermi) 22 grams, Flos Lonicerae 16 grams, Herba Agrimoniae 22 grams, Radix Glycyrrhizae 7 grams, Flos Carthami 4 grams, Radix Salviae Miltiorrhizae 16 grams, Radix Sanguisorbae 11 grams, Pollen Typhae 11 grams, Medulla Junci 4 grams, Radix Saposhnikoviae 11 grams, Rhizoma Belamcandae 16 grams, Rhizoma Imperatae 16 grams, Fructus Lycii 11 grams, Radix Isatidis 11 grams, the Rhizoma Atractylodis Macrocephalae 11 grams, Fructus Gardeniae 11 grams, Radix Scutellariae (parched) 22 grams, Rhizoma Osmundae 11 grams, Herba Cirsii 27 grams.
All the other are identical with embodiment 1.
Claims (1)
1. medicine for the treatment of anaphylactoid purpura, it is characterized in that: the raw material by following parts by weight is made: Radix Astragali 25-35 part, Radix Scrophulariae 10-14 part, Radix Rehmanniae 18-22 part, Fructus Forsythiae 18-22 part, Radix Rehmanniae Preparata 18-22 part, Radix Angelicae Sinensis 9-11 part, Radix Paeoniae Rubra 18-22 part, Cortex Moutan 7-9 part, Radix Arnebiae (Radix Lithospermi) 18-22 part, Flos Lonicerae 14-16 part, Herba Agrimoniae 18-22 part, Radix Glycyrrhizae 5-7 part, Flos Carthami 2-4 part, Radix Salviae Miltiorrhizae 14-16 part, Radix Sanguisorbae 9-11 part, Pollen Typhae 9-11 part, Medulla Junci 2-4 part, Radix Saposhnikoviae 9-11 part, Rhizoma Belamcandae 14-16 part, Rhizoma Imperatae 14-16 part, Fructus Lycii 9-11 part, Radix Isatidis 9-11 part, Rhizoma Atractylodis Macrocephalae 9-11 part, Fructus Gardeniae 9-11 part, Radix Scutellariae (parched) 18-22 part, Rhizoma Osmundae 9-11 part, Herba Cirsii 21-27 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910018417XA CN101658643B (en) | 2009-09-15 | 2009-09-15 | Medicament for treating allergic purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910018417XA CN101658643B (en) | 2009-09-15 | 2009-09-15 | Medicament for treating allergic purpura |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101658643A CN101658643A (en) | 2010-03-03 |
| CN101658643B true CN101658643B (en) | 2011-04-06 |
Family
ID=41787043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910018417XA Expired - Fee Related CN101658643B (en) | 2009-09-15 | 2009-09-15 | Medicament for treating allergic purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101658643B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810794B (en) * | 2010-04-13 | 2012-07-04 | 上海赛福化工发展有限公司 | Composition of natural plant extracts with anti-allergic effects and preparation method and use thereof |
| CN101810835A (en) * | 2010-05-26 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating purpura and preparation method thereof |
| CN102198222B (en) * | 2011-05-31 | 2013-08-14 | 刘艳菊 | Medicament for treating anaphylactoid purpura |
| CN102526514B (en) * | 2011-11-12 | 2014-02-05 | 赵增 | Medicine used for treating allergic purpura |
| CN102512596A (en) * | 2011-12-28 | 2012-06-27 | 英山县雷家店镇卫生院 | Traditional Chinese medicine for treating allergic purpura |
| CN102940793B (en) * | 2012-09-19 | 2014-12-03 | 于清 | Traditional Chinese medicine composition for treating purpura |
| CN103690803B (en) * | 2013-11-27 | 2016-02-24 | 刘闯 | A kind of Chinese medicine preparation for the treatment of anaphylactoid purpura |
| CN103735991A (en) * | 2014-01-11 | 2014-04-23 | 姜丽莎 | Traditional Chinese medicine composition for treating purpura |
| CN104324293A (en) * | 2014-11-28 | 2015-02-04 | 鲁翠花 | Traditional Chinese medicine for treating anaphylactic purpura nephritis and preparation method of traditional Chinese medicine |
| CN104587071A (en) * | 2015-02-27 | 2015-05-06 | 韩建东 | Traditional Chinese medicament for treating infantile blood-heat allergic purpura |
| CN104667020B (en) * | 2015-03-20 | 2018-06-05 | 新乡医学院第一附属医院 | A kind of pharmaceutical composition for treating anaphylactoid purpura and preparation method thereof |
| CN104906415A (en) * | 2015-06-09 | 2015-09-16 | 王婷婷 | Traditional Chinese medicine combination for treating blood-heat injuring collateral type purpura |
| CN106377691A (en) * | 2016-10-27 | 2017-02-08 | 谭奇纹 | Traditional Chinese medicine capable of treating anaphylactoid purpura |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406617A (en) * | 2001-09-04 | 2003-04-02 | 鲍少敏 | Tablets against allergic purpura |
| CN1682982A (en) * | 2005-02-22 | 2005-10-19 | 黄资源 | A Chinese medicinal pill for treating chronic nephropathy and renal insufficiency |
| CN1839953A (en) * | 2005-03-31 | 2006-10-04 | 张涌川 | Medicine for treating idiopathy thrombocytopenia peliosis |
-
2009
- 2009-09-15 CN CN200910018417XA patent/CN101658643B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406617A (en) * | 2001-09-04 | 2003-04-02 | 鲍少敏 | Tablets against allergic purpura |
| CN1682982A (en) * | 2005-02-22 | 2005-10-19 | 黄资源 | A Chinese medicinal pill for treating chronic nephropathy and renal insufficiency |
| CN1839953A (en) * | 2005-03-31 | 2006-10-04 | 张涌川 | Medicine for treating idiopathy thrombocytopenia peliosis |
Non-Patent Citations (1)
| Title |
|---|
| 韩翠翠.中医辨证论治小儿紫癜性肾炎的研究进展.《云南中医中药杂志》.2008,第29卷(第9期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101658643A (en) | 2010-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101658643B (en) | Medicament for treating allergic purpura | |
| CN101130030B (en) | Medicine composition for treating nephropathy and uses of the same | |
| CN102895456B (en) | Drug for treating polycystic ovarian syndrome | |
| CN102188583A (en) | Traditional Chinese medicine for treating infertility | |
| CN101396548A (en) | Medicine composition for treating chronic gastritis | |
| CN102028842B (en) | Medicament for treating dysmenorrhea and preparation method thereof | |
| CN100333757C (en) | Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN103251912A (en) | Medicament for treating diabetes | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102698151B (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN102430072A (en) | Traditional Chinese medicine composite for treating cough | |
| CN104173951A (en) | Traditional Chinese medicine composition for nursing and treating gastroduodenal ulcer | |
| CN102198222B (en) | Medicament for treating anaphylactoid purpura | |
| CN102114195A (en) | Anti-drug capsule prepared from pure traditional Chinese medicines | |
| CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
| CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
| CN1320899C (en) | Medicine for treating ulcer haemorrhage | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN102283993B (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN102727806B (en) | Traditional Chinese medicine for treating aplastic anemia by tonifying qi | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN102293932A (en) | Chinese medicinal composition for treating abnormal menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110406 Termination date: 20110915 |